Literature DB >> 14616547

Nanobacteria promote crystallization of psammoma bodies in ovarian cancer.

Roland Sedivy1, Walter B Battistutti.   

Abstract

Serous papillary adenocarcinomas of the ovary are often associated with microcalcifications, namely psammoma bodies. Archebacteria such as nanobacteria are, for example, involved in kidney stone formation. Nanobacteria deserve close scrutiny as their cytotoxicity and ability to cross the placenta present a potential clinical risk. In this study we investigated whether nanobacteria are associated with psammoma bodies in ovarian cancer. We identified in all seven carcinomas with multiple psammoma body nanobacterial antigens in histological specimens and in the ascitic fluid. Control cases of adenocarcinomas without such calcifications did not present nanobacterial antigens. This finding indicates that apart from non-malignant conditions, nanobacteria could also be found in cancer. Hence, nanobacterial infection may be of clinical importance as these bacteria are related to microcalifications in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616547     DOI: 10.1034/j.1600-0463.2003.1111006.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  A red herring in vascular calcification: 'nanobacteria' are protein-mineral complexes involved in biomineralization.

Authors:  Georg Schlieper; Thilo Krüger; Alexander Heiss; Willi Jahnen-Dechent
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

2.  An animal model of black pigment gallstones caused by nanobacteria.

Authors:  Limin Wang; Wenlv Shen; Jun Wen; Xin An; Liying Cao; Baoqiang Wang
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

3.  Characterization of biofilm formed by human-derived nanoparticles.

Authors:  Maria K Schwartz; Larry W Hunter; Marianne Huebner; John C Lieske; Virginia M Miller
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

4.  Biologic nanoparticles and platelet reactivity.

Authors:  Virginia M Miller; Larry W Hunter; Kevin Chu; Vivasvat Kaul; Phillip D Squillace; John C Lieske; Muthuvel Jayachandran
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

5.  Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits.

Authors:  Maria K Schwartz; John C Lieske; Larry W Hunter; Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 6.  Contribution of biologically derived nanoparticles to disease.

Authors:  Maria K Schwartz; John C Lieske; Virginia M Miller
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

Review 7.  The role of calcifying nanoparticles in biology and medicine.

Authors:  Anton G Kutikhin; Elena B Brusina; Arseniy E Yuzhalin
Journal:  Int J Nanomedicine       Date:  2012-01-19

8.  Association between calcifying nanoparticles and placental calcification.

Authors:  Yanan Guo; Dechun Zhang; He Lu; Shuang Luo; Xuecheng Shen
Journal:  Int J Nanomedicine       Date:  2012-03-27

9.  Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle.

Authors:  Maria A K Schwartz; John C Lieske; Vivek Kumar; Gerard Farell-Baril; Virginia M Miller
Journal:  Int J Nanomedicine       Date:  2008

10.  Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids.

Authors:  Cheng-Yeu Wu; Lena Young; David Young; Jan Martel; John D Young
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.